AEGON ASSET MANAGEMENT UK Plc bought a new position in The Allstate Corporation (NYSE:ALL - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,200 shares of the insurance provider's stock, valued at approximately $2,115,000.
Several other institutional investors and hedge funds have also made changes to their positions in ALL. Norges Bank purchased a new position in shares of Allstate during the fourth quarter worth approximately $531,294,000. GQG Partners LLC boosted its holdings in shares of Allstate by 36.0% in the fourth quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider's stock valued at $1,142,449,000 after purchasing an additional 1,452,993 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Allstate by 29.2% in the fourth quarter. Franklin Resources Inc. now owns 5,007,549 shares of the insurance provider's stock valued at $1,042,321,000 after purchasing an additional 1,131,172 shares during the period. Robeco Institutional Asset Management B.V. grew its stake in Allstate by 1,766.9% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 869,139 shares of the insurance provider's stock worth $180,911,000 after purchasing an additional 822,583 shares in the last quarter. Finally, Woodline Partners LP bought a new position in Allstate in the third quarter worth approximately $148,641,000. 76.47% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on ALL shares. Zacks Research lowered Allstate from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 7th. Mizuho lowered their target price on Allstate from $281.00 to $265.00 and set an "outperform" rating for the company in a report on Friday, March 20th. Keefe, Bruyette & Woods downgraded Allstate from an "outperform" rating to a "market perform" rating and dropped their price target for the stock from $266.00 to $242.00 in a research report on Monday, June 8th. Raymond James Financial restated a "strong-buy" rating and set a $260.00 price target on shares of Allstate in a research note on Tuesday, March 3rd. Finally, Weiss Ratings upgraded Allstate from a "buy (b+)" rating to a "buy (a-)" rating in a report on Monday, March 23rd. Three research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Allstate currently has a consensus rating of "Moderate Buy" and an average price target of $240.33.
Check Out Our Latest Research Report on ALL
Insider Transactions at Allstate
In other news, Director Andrea Redmond sold 2,225 shares of the business's stock in a transaction on Monday, June 1st. The stock was sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director directly owned 2,225 shares of the company's stock, valued at approximately $451,474.75. The trade was a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Mario Rizzo sold 18,578 shares of the company's stock in a transaction on Friday, May 1st. The stock was sold at an average price of $218.80, for a total value of $4,064,866.40. Following the sale, the chief operating officer owned 82,227 shares of the company's stock, valued at $17,991,267.60. This trade represents a 18.43% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 22,353 shares of company stock valued at $4,851,560. Corporate insiders own 1.55% of the company's stock.
Allstate Price Performance
NYSE ALL opened at $220.72 on Friday. The company has a market cap of $56.82 billion, a PE ratio of 4.87, a P/E/G ratio of 0.40 and a beta of 0.18. The firm's 50 day moving average price is $215.95 and its 200-day moving average price is $209.23. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Corporation has a 52-week low of $188.08 and a 52-week high of $227.62.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.65 EPS for the quarter, topping analysts' consensus estimates of $7.31 by $3.34. The company had revenue of $16.94 billion during the quarter, compared to the consensus estimate of $15.24 billion. Allstate had a net margin of 17.81% and a return on equity of 42.66%. Allstate's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.53 earnings per share. Sell-side analysts forecast that The Allstate Corporation will post 29.55 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be issued a $1.08 dividend. The ex-dividend date is Monday, June 1st. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.0%. Allstate's dividend payout ratio (DPR) is currently 9.53%.
Allstate Profile
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report